Benzoic Acid

Overweight

Boston Children's HospitalSmall moleculeN/ADormant

D

28/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 15/ 100
Competitive Position: 65/ 100

Competitive context

89 Active assets in the Overweight cohort.

Asset / Sponsor	Phase	Rating
Tirzepatide LABORATORIOS INDUFAR	Phase 4	BBB
Semaglutide Novo Nordisk A/S	Phase 4	BBB
Liraglutide University of Miami	Phase 4	BB
Metformin Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.	Phase 4	BB
Orforglipron Eli Lilly and Company	Phase 3	BB

View all 50 →

Same molecule, other indications

Benzoic Acid is also rated in:

schizophreniform disorderDormant

B

Indicative ·

57 / 100

schizoaffective disorderDormant

B

Indicative ·

57 / 100

inborn disorder of amino acid metabolismDormant

B

Indicative ·

57 / 100

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.